Azithromycin during routine well-infant visits does not reduce mortality

1. In this randomized controlled trial, infants who received a dose of azithromycin during their routine well visit had comparable mortality rates to placebo. 2. No differences were observed between the azithromycin and placebo groups with regard to rates of caregiver-reported hospitalization, sick-child clinic visits, or adverse events. Evidence Rating Level: 1 (Excellent) Study Rundown: […]

The post Azithromycin during routine well-infant visits does not reduce mortality first appeared on 2 Minute Medicine.